Caption Management’s Quest Diagnostics DGX Stock Holding History

Caption Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$7.19M	–	1743
2025 Q2	$7.19M	Hold	40,000	–	–	0.08%	301
2025 Q1	$6.77M	Buy	+40,000	New	+$6.57M	0.07%	293
2023 Q4	–	Sell	-10,000	Closed	-$1.22M	–	1405
2023 Q3	$1.22M	Sell	10,000 -79,100	-89%	-$10.5M	0.02%	722
2023 Q2	$12.5M	Sell	89,100 -65,400	-42%	-$9.02M	0.22%	113
2023 Q1	$21.9M	Buy	154,500 +55,100	+55%	+$7.88M	0.42%	53
2022 Q4	$15.6M	Buy	99,400 +9,900	+11%	+$1.42M	0.24%	101
2022 Q3	$11M	Sell	89,500 -1,200	-1%	-$158K	0.15%	155
2022 Q2	$12.1M	Hold	90,700	–	–	0.17%	149
2022 Q1	$12.4M	Buy	90,700 +5,700	+7%	+$794K	0.15%	163
2021 Q4	$14.7M	Sell	85,000 -190,000	-69%	-$28.9M	0.16%	156
2021 Q3	$40M	Sell	275,000 -600	-0.2%	-$87.8K	0.46%	29
2021 Q2	$36.4M	Buy	275,600 +180,000	+188%	+$23.6M	0.47%	30
2021 Q1	$12.3M	Buy	+95,600	New	+$11.8M	0.26%	83

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caption Management's DGX Position: Q3 2025 in Review

Caption Management sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 4,900 shares — an estimated $880K sold.

Caption Management first reported a position in DGX in Q3 2023 and held it in 3 quarters. The position peaked at $914K in Q3 2023. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Caption Management reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
Caption Management sold 4,900 Quest Diagnostics shares in Q3 2025, an estimated $880K.
Caption Management first reported a position in Quest Diagnostics in Q3 2023 and held it in 3 quarters.
Caption Management's Quest Diagnostics position peaked at $914K in Q3 2023.
1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.